<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04933487</url>
  </required_header>
  <id_info>
    <org_study_id>PHY2013</org_study_id>
    <nct_id>NCT04933487</nct_id>
  </id_info>
  <brief_title>Rotational Stability Analysis of a Toric Monofocal IOL</brief_title>
  <acronym>PHY2013</acronym>
  <official_title>Prospective Evaluation of the Rotational Stability of the Ankoris Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beaver-Visitec International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>targomedGmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Beaver-Visitec International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, prospective PMCF study whereby patients undergoing routine cataract&#xD;
      surgery will have monolateral implantation of hydrophilic monofocal toric intraocular lens&#xD;
      Ankoris.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, prospective, nonrandomized PMCF study whereby patients undergoing&#xD;
      routine cataract surgery will have monolateral implantation of hydrophilic monofocal toric&#xD;
      intraocular lens (Ankoris). The device under investigation is manufactured by the sponsor of&#xD;
      this study. The refractive power of the lens has a spherical and a cylindrical component. The&#xD;
      IOLs will be implanted in the course of routine cataract surgery and will benefit to patients&#xD;
      suffering from cataract development and showing pre-existing corneal astigmatism.&#xD;
&#xD;
      The primary objective of this study is to determine the rotational stability of the Ankoris&#xD;
      intraocular lens. The secondary objective is to measure the residual astigmatism after&#xD;
      Ankoris implantation with respect to the targeted astigmatism correction.&#xD;
&#xD;
      In total approx. 20 eyes of 20 patients will be recruited for this clinical study.&#xD;
&#xD;
      Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery. Subjects&#xD;
      would have the option for unscheduled visits if required medically.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 26, 2014</start_date>
  <completion_date type="Actual">March 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rotational stability - Photograph of IOL with dilated pupil to asses IOL rotation</measure>
    <time_frame>3 months postoperative</time_frame>
    <description>Rotational stability of the ANKORIS is evaluated on the basis of slit-lamp photographies to capture the iris and the marks onto the lens. Descriptive statistics will be used to determine the IOL stability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.</measure>
    <time_frame>Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery</time_frame>
    <description>Visual performance is determined in terms of monocular uncorrected distance visual acuity (UDVA), distance corrected visual acuity (DCVA) and postoperative refraction. Efficiency will be assessed using Alpins method.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Cataract</condition>
  <condition>Lens Opacities</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Ankoris IOL Implantation experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Monolateral implantation of toric intraocular lenses Ankoris</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation experimental</intervention_name>
    <description>Monolateral implantation of toric intraocular lenses Ankoris. (Manufactured by PhysIOL sa/nv, Liège, Belgium).</description>
    <arm_group_label>Ankoris IOL Implantation experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cataracteous Eyes with no comorbidity&#xD;
&#xD;
          -  Regular corneal astigmatism &gt;1 dioptre and &lt;3D determined by an automatic keratometer&#xD;
             (regularity determined by the topography of the keratometry).&#xD;
&#xD;
          -  Availability, willingness and sufficient cognitive awareness to comply with&#xD;
             examination procedures&#xD;
&#xD;
          -  Signed informed consent •&gt;50 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute or chronic disease or illness that would increase risk or confound study results&#xD;
             (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)&#xD;
&#xD;
          -  Any ocular comorbidity&#xD;
&#xD;
          -  History of ocular trauma or prior ocular surgery including refractive procedures&#xD;
&#xD;
          -  Capsule or zonular abnormalities that may affect postoperative centration or tilt of&#xD;
             the lens (e.g. pseudoexfoliation syndrome, Marfan's syndrome)&#xD;
&#xD;
          -  Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils&#xD;
             that do not dilate under mesopic/scotopic conditions)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Burkhard Dick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruhr-Universitat Bochum, Bochum, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ruhr-Universitat Bochum, Bochum, Germany</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intraocular Lens</keyword>
  <keyword>Monofocal</keyword>
  <keyword>Toric Lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

